News

According to Cytori, the Celution system is a European-approved, cell processing device, which extracts and makes a dose of a patient’s own adipose tissue-derived adult stem and regenerative

EpiCept will direct its resources toward the registration of Ceplene in North America and clinical development programs. When complete, these actions are expected to reduce annual expenses by

Jonathan Rowe, chief operating officer for Gene Express stated, “The partnership between Funakoshi and Gene Express is extremely valuable as Funakoshi has the experience and capability to bring

Mr Valenti was most recently vice president and general manager of surgical devices (US) for Covidien. Prior, he spent 12 years with Johnson & Johnson, serving in a

Under the agreement, the total purchase price for Immtech Life Science is $2 million in cash. The company has received 30% of the total purchase price following the

The funding was led by MC Silicon Valley/Mitsubishi International and joined by existing investors including Montreux Equity Partners, Thomas Fogarty, and CN Investment Partners. In connection with the

The lawsuit is in response to the submission of an abbreviated new drug application to the FDA by Sandoz requesting approval to manufacture and sell generic versions of

With this instrument launch Miltenyi Biotec broadens the product portfolio of the cell analysis business section and offers customers a milestone flow cytometer with novel features. According to

Under the terms of the agreement, Circ Pharma will fund the development of the product and IntelGenx will receive royalties from the product’s sales. IntelGenx will use its